FineMark National Bank & Trust - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$25,000
+4.2%
9810.0%0.00%
-33.3%
Q3 2016$24,000
+33.3%
981
+12.0%
0.00%
+50.0%
Q2 2016$18,000
+157.1%
876
+90.8%
0.00%
+100.0%
Q1 2016$7,000
+16.7%
4590.0%0.00%0.0%
Q4 2015$6,0000.0%4590.0%0.00%0.0%
Q3 2015$6,000
-62.5%
459
-52.5%
0.00%
-50.0%
Q2 2015$16,0009670.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders